Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM
Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM
复制标题
DOI：
10.1007/s12094-019-02182-z
复制
发表时间：
2020-05-01
影响因子：
3.4
通讯作者：
Suarez-Artacho, G.
中科院分区：
文献类型：
--
作者：
Vera, R.;Gonzalez-Flores, E.;Suarez-Artacho, G.
结直肠癌（CRC）是第二高的肿瘤发病率，也是癌症死亡的主要原因。近20%的CRC患者在诊断时就会出现转移，超过50%的CRC患者在病程中出现转移性疾病。来自西班牙肿瘤内科学会、西班牙外科医生协会、西班牙放射肿瘤学学会、西班牙血管和介入放射学学会以及西班牙核医学和分子影像学会的一组专家齐聚一堂，就 CRC 患者肝转移的治疗进行讨论并达成多学科共识。该小组定义了该疾病可能出现的不同情况：健康或不健康的可切除肝转移患者、潜在可切除肝转移患者以及不可切除肝转移患者。在每种情况下，都会讨论不同的策略和治疗方法。
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and the Spanish Society of Nuclear Medicine and Molecular Imaging met to discuss and provide a multidisciplinary consensus on the management of liver metastases in patients with CRC. The group defined the different scenarios in which the disease can present: fit or unfit patients with resectable liver metastases, patients with potential resectable liver metastases, and patients with unresectable liver metastases. Within each scenario, the different strategies and therapeutic approaches are discussed.